Medtronic SMall Annuli Randomized To Evolut or Sapien | Clinical Research Studies Listing

Medtronic SMall Annuli Randomized To Evolut or Sapien Trial (SMART Trial)

Recruiting

18 years - 99 years

All

Phase N/A

400 participants needed

1 Location

Brief description of study

The purpose of this study is to collect information and compare the safety and performance of self-expanding (SE) versus balloon-expandable (BE) transcatheter aortic valve replacement (TAVR) in patients with a small aortic valve.

Study participants will be randomized on a 1:1 basis to receive transcatheter aortic valve replacement (TAVR) with either a Medtronic SE or an Edwards BE TAV. Randomization will be stratified by site and gender

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: pacemaker,heart disease,cadiac resynchronization
Age: 18 years - 99 years
Gender: All

Updated on 04 Aug 2024. Study ID: 848494

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Medtronic SMall Annuli Randomized To Evolut or Sapien Trial (SMART Trial)

Brief description of study

Eligibility of study

Find a site

Interested in the study